Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1985 Aug 15;133(4):301.

Suboptimal response to hepatitis B vaccine in Nova Scotia.

PMCID: PMC1345982  PMID: 4016641

Full text

PDF

Page 301

301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Francis D. P., Hadler S. C., Thompson S. E., Maynard J. E., Ostrow D. G., Altman N., Braff E. H., O'Malley P., Hawkins D., Judson F. N. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362–366. doi: 10.7326/0003-4819-97-3-362. [DOI] [PubMed] [Google Scholar]
  2. Krugman S., Holley H. P., Jr, Davidson M., Simberkoff M. S., Matsaniotis N. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses. J Med Virol. 1981;8(2):119–121. doi: 10.1002/jmv.1890080205. [DOI] [PubMed] [Google Scholar]
  3. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES